FIELD: medicine. SUBSTANCE: method involves exposing mammalian cells to combined magnetic field having alternating and permanent constituents. The alternating constituent is produced as resultant action of two to ten frequencies the values of which are selected depending on ratio value of cell target charges to their masses in the range of 0,2×106 to 1×106. The frequency bandwidth used as basis for selecting frequencies making up the alternating constituent is within 1 to 20 Hz limits. Permanent constituent induction of the magnetic field to be produced is selected within the limits of 30 to 200 mcTesla units with requested effective action upon cytokine production being taken into account. EFFECT: high rate of cytokine production in mammalian cells. 3 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION WITH ANTIOXIDANT PROPERTY AND METHOD FOR TREATMENT OF DISEASE IN MAMMALS | 2002 |
|
RU2280448C2 |
COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSION OF OXIDATIVE PROCESS IN CASE OF TYPE 2 DIABETES | 2012 |
|
RU2535069C2 |
IMMUNOMODULATOR WITH ANTITUMOR ACTIVITY AND DRUG BASED ON THE SAME | 2005 |
|
RU2283663C1 |
METHOD FOR INITIATING TUMOR CELLS DEATH | 2006 |
|
RU2307681C1 |
METHOD FOR CORRECTING IMMUNITY STATUS IN ACNE PATIENTS | 2006 |
|
RU2320380C1 |
EMULSION OF PERFLUOROORGANIC COMPOUND EXHIBITING GAS-TRANSPORT PROPERTY | 1993 |
|
RU2088217C1 |
COMPOSITION FOR KILLING TNF-α-SENSITIVE TUMOR CELLS | 2002 |
|
RU2209078C1 |
DEVICE FOR FREEZING BIOLOGICAL OBJECTS | 1992 |
|
RU2038549C1 |
METHOD OF ACOUSTIC DETERMINATION OF ENZYME ACTIVITY OR SUBSTRATE QUANTITY IN MICROVOLUMES | 1991 |
|
RU2007460C1 |
INTERLEUKIN-10, USING IT AND BASED COMPOSITION FOR TREATING BRAIN NEURODEGENERATIVE PROCESSES | 2012 |
|
RU2538613C2 |
Authors
Dates
2003-07-10—Published
2002-07-05—Filed